Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 22959822)

1.

Walking stabilizes cognitive functioning in Alzheimer's disease (AD) across one year.

Winchester J, Dick MB, Gillen D, Reed B, Miller B, Tinklenberg J, Mungas D, Chui H, Galasko D, Hewett L, Cotman CW.

Arch Gerontol Geriatr. 2013 Jan-Feb;56(1):96-103. doi: 10.1016/j.archger.2012.06.016. Epub 2012 Sep 5.

2.

Six-month walking program changes cognitive and ADL performance in patients with Alzheimer.

Venturelli M, Scarsini R, Schena F.

Am J Alzheimers Dis Other Demen. 2011 Aug;26(5):381-8. doi: 10.1177/1533317511418956. Epub 2011 Aug 17.

PMID:
21852281
3.
4.

Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.

Hallikainen I, Hänninen T, Fraunberg M, Hongisto K, Välimäki T, Hiltunen A, Karppi P, Sivenius J, Soininen H, Koivisto AM; ALSOVA study group.

Int Psychogeriatr. 2013 Aug;25(8):1335-44. doi: 10.1017/S1041610213000653. Epub 2013 May 16.

PMID:
23676340
5.

Predictors of patient self-ratings of quality of life in Alzheimer disease: cross-sectional results from the Canadian Alzheimer's Disease Quality of Life Study.

Naglie G, Hogan DB, Krahn M, Beattie BL, Black SE, Macknight C, Freedman M, Patterson C, Borrie M, Bergman H, Byszewski A, Streiner D, Irvine J, Ritvo P, Comrie J, Kowgier M, Tomlinson G.

Am J Geriatr Psychiatry. 2011 Oct;19(10):881-90. doi: 10.1097/JGP.0b013e3182006a67.

6.

Proxy-rated quality of life in Alzheimer's disease: a three-year longitudinal study.

Vogel A, Bhattacharya S, Waldorff FB, Waldemar G.

Int Psychogeriatr. 2012 Jan;24(1):82-9. doi: 10.1017/S1041610211001128. Epub 2011 Jun 28.

PMID:
21729415
7.

Functional dependence and caregiver burden in Alzheimer's disease: a controlled trial on the benefits of motor intervention.

Canonici AP, Andrade LP, Gobbi S, Santos-Galduroz RF, Gobbi LT, Stella F.

Psychogeriatrics. 2012 Sep;12(3):186-92. doi: 10.1111/j.1479-8301.2012.00407.x.

PMID:
22994617
8.

[Perturbations of activities of daily living in Alzheimer's disease. A study of 172 patients with the using a questionnaire completed by caregivers].

Derouesné C, Thibault S, Lozeron P, Baudouin-Madec V, Piquard A, Lacomblez L.

Rev Neurol (Paris). 2002 Jul;158(6-7):684-700. French.

PMID:
12486898
9.

[Apathy in frontotemporal dementia and Alzheimer's disease: are there distinct profiles?].

Derouesné C, Lacomblez L, Fiori N, Gély-Nargeot MC, Bungener C.

Geriatr Psychol Neuropsychiatr Vieil. 2012 Mar;10(1):107-15. doi: 10.1684/pnv.2012.0315. French.

PMID:
22414405
10.

A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.

Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.

J Am Geriatr Soc. 2001 Dec;49(12):1590-9.

PMID:
11843990
11.

Determinants of the quality of life in Alzheimer's disease patients as assessed by the Japanese version of the Quality of Life-Alzheimer's disease scale.

Matsui T, Nakaaki S, Murata Y, Sato J, Shinagawa Y, Tatsumi H, Furukawa TA.

Dement Geriatr Cogn Disord. 2006;21(3):182-91. Epub 2006 Jan 9.

PMID:
16401890
12.

Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer's disease: a prospective, observational study.

Santoro A, Siviero P, Minicuci N, Bellavista E, Mishto M, Olivieri F, Marchegiani F, Chiamenti AM, Benussi L, Ghidoni R, Nacmias B, Bagnoli S, Ginestroni A, Scarpino O, Feraco E, Gianni W, Cruciani G, Paganelli R, Di Iorio A, Scognamiglio M, Grimaldi LM, Gabelli C, Sorbi S, Binetti G, Crepaldi G, Franceschi C.

CNS Drugs. 2010 Feb;24(2):163-76. doi: 10.2165/11310960-000000000-00000.

PMID:
20088621
13.
14.

Role of physical activity on the maintenance of cognition and activities of daily living in elderly with Alzheimer's disease.

Arcoverde C, Deslandes A, Rangel A, Rangel A, Pavão R, Nigri F, Engelhardt E, Laks J.

Arq Neuropsiquiatr. 2008 Jun;66(2B):323-7.

15.

Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD.

Sparks DL, Sabbagh MN, Connor DJ, Lopez J, Launer LJ, Petanceska S, Browne P, Wassar D, Johnson-Traver S, Lochhead J, Ziolkowski C.

Curr Alzheimer Res. 2005 Jul;2(3):343-53.

PMID:
15974900
16.

Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction.

Senanarong V, Cummings JL, Fairbanks L, Mega M, Masterman DM, O'Connor SM, Strickland TL.

Dement Geriatr Cogn Disord. 2004;17(1-2):14-20. Epub 2003 Oct 13.

PMID:
14560060
17.

Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.

Kashiwa Y, Kitabayashi Y, Narumoto J, Nakamura K, Ueda H, Fukui K.

Psychiatry Clin Neurosci. 2005 Dec;59(6):697-704.

PMID:
16401246
18.

Clinical utility of the functional independence measure for assessment of patients with Alzheimer's disease and vascular dementia.

Tanaka N, Nakatsuka M, Ishii H, Nakayama R, Hosaka R, Meguro K.

Psychogeriatrics. 2013 Dec;13(4):199-205. doi: 10.1111/psyg.12012. Epub 2013 Oct 28.

PMID:
24289460
19.

Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.

Lyketsos CG, DelCampo L, Steinberg M, Miles Q, Steele CD, Munro C, Baker AS, Sheppard JM, Frangakis C, Brandt J, Rabins PV.

Arch Gen Psychiatry. 2003 Jul;60(7):737-46.

PMID:
12860778
20.

The neuropsychiatric inventory scores change across the mini mental state examination ranges in patients with Alzheimer's disease: a multicenter study in Turkey.

Yener GG; Turkuaz Alzheimer Working (TAC) Group.

Cogn Behav Neurol. 2009 Dec;22(4):264-9. doi: 10.1097/WNN.0b013e3181c14737.

PMID:
19996880
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk